Monitor for imminent pricing announcement or prospectus supplement disclosing offering size and terms. Given the small market cap, even a modest offering could result in significant dilution. Watch for insider selling or short interest changes ahead of the expected offering.
Price Chart
Executive Summary
IceCure Medical Ltd. (ICCM) has received SEC effectiveness for its registration statement (File No. 333-288062), allowing it to proceed with a public offering of securities. The effectiveness date was March 23, 2026, indicating the company can now begin selling registered shares, likely in a follow-on or shelf offering given the small market cap of $47M.
Key Facts
- SEC Form EFFECT filed, confirming effectiveness of registration statement 333-288062 as of March 23, 2026
- Company is based in Caesarea, Israel, and operates in the medical devices sector (SIC 3841)
- No financial details (offering size, price, or share count) are disclosed in the EFFECT filing
- This is not an IPO — the company is already publicly traded on Nasdaq under ticker ICCM
- Effectiveness enables future issuance of securities under a shelf or follow-on offering
Financial Impact
Potential dilution possible; exact magnitude unknown — no dollar amount or share count specified in filing
Risk Factors
- Potential for near-term share dilution once offering details are announced
- Market reaction may be negative if offering is priced at a discount to current levels
- Limited liquidity due to small market cap could amplify volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000904 |
| Document: 9999999995-26-000904-index.html | 9999999995-26-000904 |
| Document: 9999999995-26-000904.txt | 9999999995-26-000904 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 6-K | $1.10 | awaiting T+60 | — | $1.03 (−6.36%) |
Oct 5, 2026 22d ago | 6-K | $1.27 | awaiting T+60 | — | $1.03 (−18.90%) |
Oct 5, 2026 22d ago | 6-K | $1.54 | awaiting T+60 | — | $1.03 (+33.12%) |
Sep 10, 2026 6w ago | 6-K | $2.14 | awaiting T+60 | — | $1.03 (−51.87%) |
Aug 24, 2026 9w ago | 6-K | $2.27 | awaiting T+60 | — | $1.03 (−54.63%) |
Aug 19, 2026 9w ago | EFFECT | $2.52 | awaiting T+60 | — | $1.03 (+59.13%) |
Aug 14, 2026 10w ago | 6-K | $2.82 | awaiting T+60 | — | $1.03 (−63.48%) |
Aug 12, 2026 10w ago | 6-K | $3.11 | awaiting T+60 | — | $1.03 (−66.83%) |
Jul 6, 2026 16w ago | EFFECT | $4.61 $1.59 | ▲ +65.51% | ▲ +67.23% | $1.03 (+77.66%) |
Jun 26, 2026 17w ago | 6-K | $5.26 $1.95 | ▲ +62.93% | ▲ +67.31% | $1.03 (+80.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers